Anti-IL-13Ra2/CD213a2 Antibody (Wake Forest U. patent anti-IL-13RA2)
Catalog No.
F2009
Anti-IL-13Ra2/CD213a2 Antibody (Wake Forest U. patent anti-IL-13RA2)
Featured Products
Wake Forest U. patent anti-IL-13RA2 is a CHO expressed human antibody targeting IL-13Ra2/CD213a2.
Quality Control & DataSheet
- View current batch:
-
Purity > 90% by SDS-PAGE and SEC-HPLC analyses.
- MSDS (Material Safety Data Sheet)
- Datasheet
150 kDa
Dry ice
-80°C
2 years
Liquid
See label
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
Wake Forest U. patent anti-IL-13RA2
100 mM Pro 20 mM Arg pH 5.0. No preservative!
Q14627
Human
Unconjugated
Monoclonal
Protein A
IgG1
ELISA, FACS, Kinetics, Functional assay, Animal Model
IL-13Ra2 / CD213a2
Please avoid freeze-thaw cycles.